{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:19:09Z","timestamp":1794561549676,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["413490537"],"award-info":[{"award-number":["413490537"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["525136051"],"award-info":[{"award-number":["525136051"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002869","name":"Christian-Albrechts-Universit\u00e4t zu Kiel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.lanepe.2025.101503","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T17:34:54Z","timestamp":1760808894000},"page":"101503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysis"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4519-1002","authenticated-orcid":false,"given":"David","family":"Baden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3068-3899","authenticated-orcid":false,"given":"Nadine","family":"Wolgast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp M.","family":"Altrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Steinh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4547-9260","authenticated-orcid":false,"given":"Jakob","family":"Voran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Beder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2086-5481","authenticated-orcid":false,"given":"Manuel","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Baden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Bastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Ronckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"M\u00fcller-Nordhorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo-Zin","family":"Kim-Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fransecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Cario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"R\u00f6llig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Katalinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D.","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lanepe.2025.101503_bib1","first-page":"1","article-title":"Immunotherapy in hematologic malignancies: achievements, challenges and future prospects","volume":"8","author":"Tang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101503_bib2","doi-asserted-by":"crossref","DOI":"10.1182\/hem.V21.6.202463","article-title":"Then and now - treatment for acute leukaemia in older adults: two decades of remarkable progress","volume":"21","author":"Salman","year":"2024","journal-title":"Hematologist"},{"issue":"16","key":"10.1016\/j.lanepe.2025.101503_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute lymphoblastic leukaemia in children","volume":"373","author":"Hunger","year":"2015","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.lanepe.2025.101503_bib4","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1002\/cncr.33458","article-title":"De novo acute myeloid leukaemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017","volume":"127","author":"Sasaki","year":"2021","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101503_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/ejh.13247","article-title":"Survival in adult acute lymphoblastic leukaemia (ALL): a report from the Swedish ALL registry","volume":"103","author":"Lennmyr","year":"2019","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101503_bib6","first-page":"487","article-title":"Epidemiology's contribution to health service management and planning in developing countries: a missing link","volume":"70","author":"Unger","year":"1992","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanepe.2025.101503_bib7","first-page":"413","article-title":"Cancer registries can provide evidence-based data to improve quality of care and prevent cancer deaths","volume":"8","author":"Bouchardy","year":"2014","journal-title":"Ecancermedicalscience"},{"issue":"17","key":"10.1016\/j.lanepe.2025.101503_bib8","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1182\/bloodadvances.2024013102","article-title":"Impact of patient demographics on treatment outcomes in AML: a population-based registry in England, 2013-2020","volume":"8","author":"Liu","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101503_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/leu.2014.234","article-title":"Comorbidity and performance status in acute myeloid leukaemia patients: a nation-wide population-based cohort study","volume":"29","author":"\u00d8stg\u00e5rd","year":"2015","journal-title":"Leukaemia"},{"key":"10.1016\/j.lanepe.2025.101503_bib12","series-title":"Ungleichheit, Umverteilung und Preise im regionalen Vergleich","author":"Seils","year":"2022"},{"key":"10.1016\/j.lanepe.2025.101503_bib13","author":"Michalski"},{"issue":"8","key":"10.1016\/j.lanepe.2025.101503_bib16","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3390\/jcm10081657","article-title":"Flexible modeling of net survival and cure by AML subtype and age: a French population-based study from FRANCIM","volume":"10","author":"Mounier","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.lanepe.2025.101503_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115231","article-title":"Long-term survival for myeloid neoplasms and national health expenditure: a EUROCARE-6 retrospective, population-based study","volume":"220","author":"Vener","year":"2025","journal-title":"Eur J Cancer"},{"issue":"18","key":"10.1016\/j.lanepe.2025.101503_bib18","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/blood-2008-07-172007","article-title":"Age and acute myeloid leukaemia: real world data on decision to treat and outcomes from the Swedish acute leukaemia registry","volume":"113","author":"Juliusson","year":"2009","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.lanepe.2025.101503_bib19","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.3390\/cancers15184618","article-title":"Venetoclax with hypomethylating agents in newly diagnosed acute myeloid leukaemia: a systematic review and meta-analysis of survival data from real-world studies","volume":"15","author":"Ucciero","year":"2023","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.lanepe.2025.101503_bib20","first-page":"1627","article-title":"Acute lymphoblastic leukaemia: an assessment of international incidence, survival, and disease burden","volume":"26","author":"Katz","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101503_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00277-021-04738-y","article-title":"Evaluating outcomes of adult patients with acute lymphoblastic leukaemia and lymphoblastic lymphoma treated on the GMALL 07\/2003 protocol","volume":"101","author":"Fredman","year":"2022","journal-title":"Ann Hematol"},{"issue":"Supplement 1","key":"10.1016\/j.lanepe.2025.101503_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood-2024-201217","article-title":"Update on GMALL trial 08\/2013 shows durable favorable outcome of newly diagnosed adult Philadelphia-positive acute lymphoblastic leukaemia (Ph+ALL) with Imatinib, dose-reduced induction followed by stem cell transplantation","volume":"144","author":"Pfeifer","year":"2024","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.lanepe.2025.101503_bib23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajh.26156","article-title":"Acute lymphoblastic leukaemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980\u20132017","volume":"96","author":"Sasaki","year":"2021","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1016\/j.lanepe.2025.101503_bib24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/cncr.34150","article-title":"Sex-based disparities in outcome in pediatric acute lymphoblastic leukaemia: a Children's Oncology Group report","volume":"128","author":"Gupta","year":"2022","journal-title":"Cancer"},{"issue":"22","key":"10.1016\/j.lanepe.2025.101503_bib25","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1182\/blood.V114.22.2289.2289","article-title":"Proportion of adult AML patient population receiving allogeneic stem cell transplantation and long-term outcome: real world data from the Swedish national acute leukaemia registry","volume":"114","author":"Juliusson","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.lanepe.2025.101503_bib26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/joim.12854","article-title":"Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP\/EBMT analysis","volume":"285","author":"Canaani","year":"2019","journal-title":"J Intern Med"},{"issue":"3","key":"10.1016\/j.lanepe.2025.101503_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2023.101485","article-title":"The current landscape: allogeneic hematopoietic stem cell transplant for acute lymphoblastic leukaemia","volume":"36","author":"Prockop","year":"2023","journal-title":"Best Pract Res Clin Haematol"},{"issue":"2","key":"10.1016\/j.lanepe.2025.101503_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10389-016-0767-y","article-title":"Patients with acute myelogenous leukaemia (AML) from a socially disadvantaged environment show poorer therapeutic outcome","volume":"25","author":"Kaifie","year":"2017","journal-title":"J Public Health"},{"issue":"11","key":"10.1016\/j.lanepe.2025.101503_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.41651","article-title":"Neighborhood deprivation and DNA methylation and expression of cancer genes in breast tumors","volume":"6","author":"Jenkins","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.lanepe.2025.101503_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.43198","article-title":"Global disparities of cancer and its projected burden in 2050","volume":"7","author":"Bizuayehu","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225002959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776225002959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:57:19Z","timestamp":1773363439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776225002959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"alternative-id":["S2666776225002959"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101503","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology, survival, and treatment of acute myeloid and lymphoblastic leukaemia in Germany: a nationwide population-based registry analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2025.101503","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101503"}}